Pharmanutra SpA

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 23.86% vs 11.39% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 41.67% vs -7.69% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.70",
          "val2": "26.40",
          "chgp": "23.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.60",
          "val2": "4.60",
          "chgp": "21.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.30",
          "chgp": "-66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.40",
          "val2": "2.40",
          "chgp": "41.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "144.80%",
          "val2": "145.10%",
          "chgp": "-0.03%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 14.03% vs 15.27% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 19.88% vs 29.69% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "131.70",
          "val2": "115.50",
          "chgp": "14.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.30",
          "val2": "30.20",
          "chgp": "6.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "1.70",
          "chgp": "-35.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.20",
          "val2": "0.30",
          "chgp": "300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "19.90",
          "val2": "16.60",
          "chgp": "19.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "219.20%",
          "val2": "232.90%",
          "chgp": "-1.37%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

32.70

26.40

23.86%

Operating Profit (PBDIT) excl Other Income

5.60

4.60

21.74%

Interest

0.20

0.30

-33.33%

Exceptional Items

0.10

0.30

-66.67%

Consolidate Net Profit

3.40

2.40

41.67%

Operating Profit Margin (Excl OI)

144.80%

145.10%

-0.03%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 23.86% vs 11.39% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 41.67% vs -7.69% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

131.70

115.50

14.03%

Operating Profit (PBDIT) excl Other Income

32.30

30.20

6.95%

Interest

1.10

1.70

-35.29%

Exceptional Items

1.20

0.30

300.00%

Consolidate Net Profit

19.90

16.60

19.88%

Operating Profit Margin (Excl OI)

219.20%

232.90%

-1.37%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 14.03% vs 15.27% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 19.88% vs 29.69% in Dec 2024

All Annual Results